Beginning with the royalties received from Harry Steenbock's vitamin D invention, WARF has set aside funds to build a perpetual endowment to support, encourage and aid research at the University of Wisconsin. More recently, the endowment also has supported scientific programs at the Morgridge Institute for Research, a biomedical research organization that works to solve major challenges to human health in collaboration with the university.

$2.68 Billion in Total Portfolio Assets

(as of June 30, 2015)
Total Portfolio Assets
Through prudent investment management and oversight, WARF’s endowment has grown to more than $2.6 billion (as of June 30, 2015). The endowment’s portfolio comprises restricted and unrestricted funds. Approximately 80% of the assets are unrestricted. Donor-directed funds are managed according to the wishes of the donor, while royalty funds are managed on behalf of the department from which the royalties were derived. WARF also manages funds on behalf of the Morgridge Institute for Research.